Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
11/01/2005 | US6960709 Method for altering the nutritional content of plant seed |
11/01/2005 | US6960650 Nucleotide sequences coding proteins for use in the treatment of tumors |
11/01/2005 | US6960559 Neurite growth regulatory factors |
11/01/2005 | US6960471 For cancer diagnostics |
11/01/2005 | US6960469 Adenoviral vectors encoding an antibody fused to a CD4 extracellular domain |
11/01/2005 | US6960451 Proteolytic fermenter |
11/01/2005 | US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation |
11/01/2005 | US6960441 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, inflammation and infections; for use as cosmetic, pesticide and antibiotic |
11/01/2005 | US6960440 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
11/01/2005 | US6960435 Amyloid β protein agglutination-controlling factor |
11/01/2005 | US6960431 Inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof and peptide associated with a transporter that is capable of |
11/01/2005 | US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
11/01/2005 | CA2294078C C-peptide specific assay procedure |
10/30/2005 | CA2507566A1 Carnobacterium divergens m35 and bacteriocin produced therefrom |
10/27/2005 | WO2005101017A1 Mass spectrometry of antibody conjugates |
10/27/2005 | WO2005100586A2 Method for construction and use of kluyveromyces lactis promoter variants in k.lactis that substantially lack e. coli transcriptional capability |
10/27/2005 | WO2005100585A2 Methods for obtaining directionally truncated polypeptides |
10/27/2005 | WO2005100584A2 Production of galactosylated glycoproteins in lower eukaryotes |
10/27/2005 | WO2005100567A1 Gene encoding guanine nucleotide exchange factor and its gene product |
10/27/2005 | WO2005100563A1 Follistatin mutant polypeptide |
10/27/2005 | WO2005100561A1 Translation controlling polynucleotide |
10/27/2005 | WO2005100398A1 Method of preparing antibody library |
10/27/2005 | WO2005100388A1 Production of insulinotropic peptides |
10/27/2005 | WO2005099745A2 Gcp-170 fusion proteins and uses thereof |
10/27/2005 | WO2005099741A1 Remedy for motoneuron diseases |
10/27/2005 | WO2005089524A9 Compositions and methods for detection of single molecules |
10/27/2005 | WO2005052000A3 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
10/27/2005 | WO2005012531A3 Antibody cdr polypeptide sequences with restricted diversity |
10/27/2005 | WO2004101740A3 Clotting factor-fc chimeric proteins to treat hemophilia |
10/27/2005 | WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
10/27/2005 | US20050241006 Human antibodies derived from immunized xenomice |
10/27/2005 | US20050240012 Bispecific molecules for use in inducing antibody dependent effector cell-mediated cytotoxicity |
10/27/2005 | US20050240006 Cytoplasmic region with more than 107 or less than 104 amino acids, a transmembrance region, and an extracellular region; nucleic acids and antibodies; diagnosing hematopoietic cell malignancy or autoimmune disease |
10/27/2005 | US20050239730 Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine |
10/27/2005 | US20050239689 Vancomycin analogs and methods thereof |
10/27/2005 | US20050239209 Method for peptide and polypeptide purification and differential analysis |
10/27/2005 | US20050239203 Regulation of endogenous gene expression in cells using zinc finger proteins |
10/27/2005 | US20050239172 Methods and DNA constructs for high yield production of polypeptides |
10/27/2005 | US20050239171 Method for purifying factor VIII/vWF-complex by means of cation exchange chromatography |
10/27/2005 | US20050239170 Alpha-MSH related compounds and methods of use |
10/27/2005 | US20050239168 Detecting moderators of kinase peptide; encoding genes |
10/27/2005 | US20050239167 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
10/27/2005 | US20050239165 Method for cultivation of the nitrile-hydratase-producing strain Rhodococcus rhodochrous M33 |
10/27/2005 | US20050239164 Glutathione production |
10/27/2005 | US20050239163 Cloning, expression and functional characterization of a mammalian DNA-R gene; polypetide having amino acid sequence with deletion at 1133 1171 amino acids |
10/27/2005 | US20050239141 Modified antibody variable domains |
10/27/2005 | US20050239126 Proteases |
10/27/2005 | US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
10/27/2005 | US20050239099 27 human secreted proteins |
10/27/2005 | US20050239081 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying |
10/27/2005 | US20050239074 Hansenula polymorpha yapsin deficient mutant strain and process for the preparation of recombinant proteins using the same |
10/27/2005 | US20050238678 Hydrogels from biopolymers |
10/27/2005 | US20050238669 Animal product free system and process for purifying a botulinum toxin |
10/27/2005 | US20050238668 Media for clostridium bacterium and processes for obtaining a clostridial toxin |
10/27/2005 | US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same |
10/27/2005 | US20050238607 FGF-5 supported and binding peptides |
10/27/2005 | DE102004016985A1 Aerosolerzeugungsvorrichtung und Inhalationsvorrichtung damit Aerosol generating device and inhalation device so that |
10/27/2005 | CA2563266A1 Kluyveromyces lactis promoter variants lacking e. coli transcriptional capability |
10/27/2005 | CA2562885A1 Follistatin variant polypeptide |
10/27/2005 | CA2562772A1 Production of galactosylated glycoproteins in lower eukaryotes |
10/27/2005 | CA2559870A1 Mass spectrometry of antibody conjugates |
10/26/2005 | EP1589107A1 Immunoglobulins devoid of light chains |
10/26/2005 | EP1589033A1 Antibody and use thereof |
10/26/2005 | EP1588713A1 Production of human papillomavirus HBV-11 capsid protein L1 and virus-like particles |
10/26/2005 | EP1588712A1 Modulators of regulatory proteins |
10/26/2005 | EP1587941A1 Method for producing alpha-l-aspartyl-l-phenylalanine-beta-ester and method for producing alpha-l-aspartyl-l-phenylalanine-alpha-methyl ester |
10/26/2005 | EP1587923A2 Improved constructs for expressing lysosomal polypeptides |
10/26/2005 | EP1587921A2 Fusion constructs and use of same to produce antibodies with increased fc receptor binding affinity and effector function |
10/26/2005 | EP1587904A2 Glycosylation modified il-20 |
10/26/2005 | EP1587541A2 Compositions and methods of tolerizing a primate to an antigen |
10/26/2005 | EP1509540A4 Claudin polypeptides, polynucleotides, and methods of making and use thereof |
10/26/2005 | EP0973889B1 HUMAN CALCIUM CHANNELS ALFA1i SUBUNITS AND RELATED PROBES, CELL LINES AND METHODS |
10/26/2005 | EP0687301B1 Prohormone convertase transformed cells and polypeptide synthesis |
10/26/2005 | EP0625048B2 Synthesis of human procollagens and collagens in recombinant dna systems |
10/26/2005 | EP0506757B2 A recombinant human factor viii derivative |
10/26/2005 | CN1688703A Methods and materials for the production of L-lactic acid in yeast |
10/26/2005 | CN1688604A Recombinant anti-osteopontin antibody and use thereof |
10/26/2005 | CN1688338A Method of humanizing immune system molecules |
10/26/2005 | CN1688335A Continuous cell line for the production of vaccines |
10/26/2005 | CN1688198A Induction of gene expression using a high concentration sugar mixture |
10/26/2005 | CN1687445A Recombined full length human brain red element, preparation method and application thereof |
10/26/2005 | CN1687444A Method for preparing peptide of decrease blood pressure in laver by using enzyme-membrane coupling technique and application thereof |
10/26/2005 | CN1687443A Method for preparing recombined human atrial natriuretic peptide rhANP by using ferment in high density |
10/26/2005 | CN1687442A Proteinic small peptide of Placenta and preparation method thereof |
10/26/2005 | CN1687441A III type proteinic small peptide and preparation technique thereof |
10/26/2005 | CN1687440A Simplified method for extracting a great lot phycocyanin |
10/26/2005 | CN1687401A Culture medium its rpeparation method and method for culturing lact-streptocin |
10/26/2005 | CN1224710C Novel human lysozyme gene, its encoding polypeptide and the method for preparing them |
10/26/2005 | CN1224704C Preparing method for recombinant chBJSTWO protein |
10/26/2005 | CN1224627C Modified factor VIII |
10/25/2005 | US6958387 Human serpin polypeptides |
10/25/2005 | US6958386 MUM-1 protein expressed by multiple myeloma-related gene |
10/25/2005 | US6958320 Sel-12 related methods |
10/25/2005 | US6958235 Recombinant protein containing a C-terminal fragment of plasmodium MSP-1 |
10/25/2005 | US6958223 Methods for producing extracellular matrix proteins |
10/25/2005 | US6958222 Methane or methanol as sole carbon source; Embden-Meyerhof carbon pathway comprising a gene encoding a pyrophosphate dependent phosphofructokinase; biomass contains protein, carbohydrates and pigment on industrial scale |
10/25/2005 | US6958214 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
10/25/2005 | US6958152 Human phospholipase C delta 5 |
10/25/2005 | US6958147 Use of VEGF-C to prevent restenosis |
10/25/2005 | CA2429724C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes |